drugset / Trial / NCT01405846

Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

NCT01405846 ↗

NaSingle-groupOpen-labelTreatment

Summary

We are going to use a special type of bronchoscopy test to examine patients who have had previous surgical treatment for lung cancer or head and neck cancer. The aim is to determine a) whether we can identify precancerous changes in their airways b) whether this type of testing is acceptable and c) get an initial idea of whether a new drug called gefitinib has any effect on precancerous areas in the airway.

Timeline

Start
2011-12
Primary completion
2016-04
Completion
2016-06

Outcome

Outcome not reported

Stopped: “Futility”

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule 250 mg —